Abstract
Overweight and obesity are one of the most difficult medical and social problems of our time. Modern society is characterized by factors that cause obesity: sedentary lifestyle, irrational diet with a large proportion of refined foods, overeating, psychological stress, etc. However, the role of eating behavior (EB) disturbances in the formation of overweight and obesity has been insufficiently studied. The aim of the work is to determine the features of different types of EB in overweight and obesity depending on gender and age factors. Material and methods. There were surveyed 210 patients (105 women and 105 men). The age of women ranged from 19 to 60 years (mean age was 41.5±11.2 years), the age of men — from 22 to 60 years (mean age — 42.3±12.3 years). All patients were divided into two clinical groups: group 1 – 70 people (35 women and 35 men) with excess weight (body mass index (BMI) was from 25.8 to 29.3 kg/m2, average 27.5±1.31 kg/m2); group 2 – 72 people (36 women and 36 men) with the 1st degree obesity (BMI from 30.0 to 33.9 kg/m2; average 31.74±1.03 kg/m2). The control group consisted of 70 people (35 women and 35 men) with normal weight (BMI from 19.5 kg/m2 to 23.9 kg/m2; average 22.41±1.43 kg/m2). EB disorders were assessed using the Dutch Eating Behavior Questionnaire (DEBQ). Results. In patients of the 1st and 2nd groups, a healthy type of CP was recorded less often than in the control group, 5.38 times (D=13.561, p<0.01) and 10.45 times of EB among women was recorded 1.7 times more often than in men (D=0.852, p<0.01). In 2nd group, the restrictive type of EB among men was recorded 1.3 times less often than among women (D=0.382, p<0.01). Conclusions. Restrictive disorders of EB are one of the leading factors in the development of overweight and obesity. Correction of eating disorders in obese people should be made taking into account the gender and age characteristics of the patient to obtain positive results with a shorter course of treatment.
(D=21.043, p<0.05), respectively. In the 1st group, the restrictive type of EB among women was recorded 1.7 times more often than in men (D=0.852, p<0.01). In 2nd group, the restrictive type of EB among men was recorded 1.3 times less often than among women (D=0.382, p<0.01). Conclusions. Restrictive disorders of EB are one of the leading factors in the development of overweight and obesity. Correction of eating disorders in obese people should be made taking into account the gender and age characteristics of the patient to obtain positive results with a shorter course of treatment.
References
Абсалямова ЛМ. Харчова поведінка жінок: розлади та психокорек¬ція. Харків: «Стильна типографія»; 2019. 393 с. (Absalyamova LM. Food behavior of women: disorders and psychocorrection. Kharkiv: «Stylish Printing House»; 2019. 393 p. Ukrainian).
Абсалямова ЛМ. Психологія харчової поведінки людини. Харків: «Смугаста типографія»; 2017. 181 с. (Absalyamova LM Psychology of human eating behavior. Kharkiv: Striped Printing House; 2017. 181 p. Ukrainian).
Пономарева ЛГ. Современные представления о расстрой¬ствах пищевого поведения. Молодой ученый. 2016;(10):274-6 (Ponomareva LG. Current views on eating disorders. Young Scientist. 2016;(10):274-6. Russian).
Окорочкова ИА, Бабий АТ, Федорцова Л. К вопросу о диагнос¬тике, лечении и обучении больных алиментарным ожирением с нарушением пищевого поведения. Здоровое питание: воспитание, образование, реклама. Всероссийская конференция, 6-я. Москва; 2013; 144-5 (Okorochkova IA, Babiy AT, Fedortsova LP. On the issue of diagnostics, treatment and education of patients with alimentary obesity with eating disorders. Healthy eating: upbringing, education, advertising. All-Russian conference, 6th. Moskwa: 2013; 144-5. Russian).
Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019 May;15(5):288-98.
Albashir AAD. The potential impacts of obesity on COVID-19. Clin Med (Lond). 2020 Jul;20(4):e109-e113.
De Lorenzo A, Romano L, Di Renzo L, Di Lorenzo N, Cenname G, Gualtieri P. Obesity: A preventable, treatable, but relapsing disease. Nutrition. 2020 Mar;71:110615.
McCafferty BJ, Hill JO, Gunn AJ. Obesity: Scope, lifestyle interventions, and medical management. Tech Vasc Interv Radiol. 2020 Mar;23(1):100653.
Holt RI. Obesity — an epidemic of the twenty-first century: an update for psychiatrists. J Psychopharmacol. 2005 Nov;19(6 Suppl):6-15.
Treasure J, Duarte TA, Schmidt U. Eating disorders. Lancet. 2020 Mar 14;395(10227):899-911.
Mairs R, Nicholls D. Assessment and treatment of eating disorders in children and adolescents. Arch Dis Child. 2016 Dec;101(12):1168-75.
Couturier J, Isserlin L, Spettigue W, Norris M. Psychotropic medication for children and adolescents with eating disorders. Child Adolesc Psychiatr Clin N Am. 2019 Oct;28(4):583-92.
Thiel A. Sind Psychopharmaka für die Behandlung der Anorexia und Bulimia nervosa notwending? [Are psychotropic drugs necessary for the treatment of anorexia and bulimia nervosa?]. Psychother Psychosom Med Psychol. 1997 Sep-Oct;47(9-10):332-45. German.
Mayer LE, Walsh BT. The use of selective serotonin reuptake inhibitors in eating disorders. J Clin Psychiatry. 1998;59 Suppl 15:28-34.
Krüger S, Kennedy SH. Psychopharmacotherapy of anorexia nervosa, bulimia nervosa and binge-eating disorder. J Psychiatry Neurosci. 2000 Nov;25(5):497-508.
Gómez Puente JM, Martínez-Marcos M. Overweight and obesity: effectiveness of interventions in adults. Enferm Clin. 2018 Jan- Feb;28(1):65-74. English, Spanish.
LeBlanc EL, Patnode CD, Webber EM, Redmond N, Rushkin M, O’Connor EA. Behavioral and pharmacotherapy weight loss interventions to prevent obesity-related morbidity and mortality in adults: Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018 Sep 18;320(11):1172-91.
The Lancet. 2019: the year for nutrition. Lancet. 2019 Jan 19; 393(10168):200.